Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel O Herzig

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Annals of Surgery|August 14, 2014
Addressing the appropriateness of elective colon resection for diverticulitis: a report from the SCOAP CERTAIN collaborativeVlad V Simianu, Amir L Bastawrous, Richard P Billingham, et al.
Journal of Surgical Oncology|May 6, 2022
Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established programBrett S Walker, Kevin G Billingsley, Thomas L Sutton, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologistsJehan Belal Yahya, Daniel O Herzig, Matthew Joseph Farrell, et al.
Annals of Surgical Oncology|August 8, 2021
Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal CancersBrett S Walker, Thomas L Sutton, Luai Zarour, et al.
International Journal of Surgery (London, England)|November 11, 2020
Assessment of a circular powered stapler for creation of anastomosis in left-sided colorectal surgery: A prospective cohort studyDaniel O Herzig, James W Ogilvie, Allen Chudzinski, et al.
The Lancet. Oncology|July 19, 2015
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S Chow, David D Smith, et al.
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Clinical Colorectal Cancer|March 4, 2026
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE StudyEmerson Y Chen, Nima Nabavizadeh, Nicholas D Kendsersky, et al.
JAMA Network Open|January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical TrialHannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Annals of Surgery|August 14, 2014
Addressing the appropriateness of elective colon resection for diverticulitis: a report from the SCOAP CERTAIN collaborativeVlad V Simianu, Amir L Bastawrous, Richard P Billingham, et al.
Journal of Surgical Oncology|May 6, 2022
Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established programBrett S Walker, Kevin G Billingsley, Thomas L Sutton, et al.
Journal of Gastrointestinal Oncology|July 13, 2018
Does a fine line exist between regional and metastatic pelvic lymph nodes in rectal cancer-striking discordance between national guidelines and treatment recommendations by US radiation oncologistsJehan Belal Yahya, Daniel O Herzig, Matthew Joseph Farrell, et al.
Annals of Surgical Oncology|August 8, 2021
Circulating Hybrid Cells: A Novel Liquid Biomarker of Treatment Response in Gastrointestinal CancersBrett S Walker, Thomas L Sutton, Luai Zarour, et al.
International Journal of Surgery (London, England)|November 11, 2020
Assessment of a circular powered stapler for creation of anastomosis in left-sided colorectal surgery: A prospective cohort studyDaniel O Herzig, James W Ogilvie, Allen Chudzinski, et al.
The Lancet. Oncology|July 19, 2015
Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trialJulio Garcia-Aguilar, Oliver S Chow, David D Smith, et al.
Diseases of the Colon and Rectum|September 8, 2018
Consolidation mFOLFOX6 Chemotherapy After Chemoradiotherapy Improves Survival in Patients With Locally Advanced Rectal Cancer: Final Results of a Multicenter Phase II TrialMichael R Marco, Lihong Zhou, Sujata Patil, et al.
Clinical Colorectal Cancer|March 4, 2026
Phase Ib Study to Assess the Safety of Neoadjuvant Trifluridine/Tipiracil With Concurrent Radiation in Resectable Stage II/III Rectal Cancer: The FIERCE StudyEmerson Y Chen, Nima Nabavizadeh, Nicholas D Kendsersky, et al.
JAMA Network Open|January 9, 2024
Organ Preservation and Survival by Clinical Response Grade in Patients With Rectal Cancer Treated With Total Neoadjuvant Therapy: A Secondary Analysis of the OPRA Randomized Clinical TrialHannah M Thompson, Dana M Omer, Sabrina Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.
Pageof 6